Get involved in our
pivotal achievements


Founded in 2002, 5AM Ventures is a leading life science venture capital firm with ~$1 billion under management. With a focus on biopharmaceuticals, drug delivery technologies and life science instruments, 5AM strategically invests in first institutional VC rounds with significant reserves for follow-on investments. The team is comprised of 17 investment professionals with offices in San Francisco, CA and Boston, MA.

Abingworth is an international investment group focused on collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life science sectors. Abingworth has invested in 147 life science companies, leading to 64 IPOs and 42 mergers and acquisitions.


LSP is a leading independent European investment firm, providing financing for private and public life-science companies and investing in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over USD 1 billion of investment capital raised to date, LSP is one of Europe’s largest and most experienced specialist life-science investors.

Versant Ventures is a leading healthcare investment firm committed to helping the next generation of great companies. The firm invests across the healthcare sector with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in Canada, the U.S. and Europe, Versant has built a team with deep investment, operating and scientific expertise that enables a hands-on approach to company building.

error: Content is protected !!!